Valuation
- Market cap
- 7,000
- Revenue TTM
- $0
- Net income TTM
- $-240,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- 32,796
- Day's range
- $0.00 – $0.00
- Shares out
- 70,772,000
- Stochastic %K
- 50%
- Beta
- -0.87
- Analysts
- —
- Price target
- —
Company profile
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 303 495 7583
- Website
- https://www.nexienbiopharma.com
- Address
- 4340 East Kentucky Avenue, Suite 206, Glendale, United States
Latest news
No headlines yet.
